Also, synthesised herbal-mediated AgNPs are the therapeutic target in treating type 2 diabetes due to their ability to inhibit protein tyrosine phosphatase 1B (PTP1B), which is the major negative regulator of the insulin signalling pathway (Shanker et al., 2017). The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.